Viewing nowCombinationTruEmpagliflozin 25/5 mg Tablet (Empagliflozin, Linagliptin)
Empagliflozin 25mg · Linagliptin 5mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.

MFDS item code 202502389 · Approved 2025.09.09
Improvement of glycemic control in patients with type 2 diabetes mellitus
This medication is used in conjunction with dietary and exercise therapy to help control blood sugar in patients with type 2 diabetes. The combination of empagliflozin and linagliptin effectively aids in improving blood sugar levels.
The recommended starting dose of this medicine is empagliflozin 10 mg/linagliptin 5 mg once daily. If empagliflozin 10 mg/linagliptin 5 mg is tolerated and additional glycemic control is needed, the dose of this medicine may be increased to 25/5 mg once daily. Patients switching to this medicine from concomitant therapy with empagliflozin and linagliptin should receive their previous doses. This medicine may be taken with or without food. Swallow the tablet whole. If a dose is missed, take it as soon as remembered. However, if the next dose is due within 12 hours, skip the missed dose and take the next dose at the usual scheduled time. Do not take a double dose in one day. Patients with renal impairment This medicine is not recommended for patients with an estimated glomerular filtration rate (eGFR) below 45 ml/min/1.73m2 for the purpose of improving glycemic control. No dose adjustment is necessary in patients with an estimated glomerular filtration rate of 45 ml/min/1.73m2 or higher. Patients with hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. Elderly patients No dose adjustment based on age is necessary. Renal function and the risk of volume depletion should be considered in patients aged 75 years and older.
This medication contains two ingredients, empagliflozin and linagliptin. It is used to assist in blood sugar control in patients with type 2 diabetes. This medication should not be used in certain patients. For example, individuals with an allergy to any of the components, patients with type 1 diabetes, those with diabetic ketoacidosis, and patients undergoing dialysis should not take this medication. Patients with impaired kidney function should regularly undergo renal function tests before taking this medication, and patients with heart failure should also use it with caution. Additionally, if symptoms such as acute pancreatitis or bullous pemphigoid (blistering skin disease) occur while taking this medication, the medication should be stopped immediately and a doctor should be consulted. The most common side effect when taking this medication is urinary tract infection, although rare side effects may include ketoacidosis, pancreatitis, allergic reactions, and hypoglycemia. The risk of hypoglycemia may be heightened, especially when this medication is taken in conjunction with insulin or sulfonylureas, and caution is required. Fluid volume depletion or hypotension may occur, so patients who are being treated for hypertension or have low blood pressure, as well as elderly individuals over 75 years old, should exercise special caution when taking this medication. This medication may also increase the risk of genital fungal infections, so appropriate treatment may be necessary if related symptoms arise. Extra caution is needed when driving or operating machinery due to the risk of hypoglycemia. It is advisable for women who are pregnant or breastfeeding to avoid using this medication, and it is recommended that children under the age of 18 do not take it as its safety and efficacy have not been established. There is no specific antidote for overdose, so appropriate treatment should be administered according to symptoms, and this medication should be stored in its original container in a safe place out of the reach of children.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to protect it from air and moisture. It is important to maintain storage temperatures between 1 and 30 degrees Celsius. Proper storage will help maintain the effectiveness and safety of the medication.
Pale pink, convex, round film-coated tablet
30 tablets/box [(10 tablets/PTP x 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin 25mg · Linagliptin 5mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 10mg · Linagliptin 5mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 25mg · Linagliptin 5mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 25mg · Linagliptin 5mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 10mg · Linagliptin 5mg
Tablet · Prescription medication · Combination
Dongkoo Bio Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 10mg · Linagliptin 5mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
Empagliflozin 25mg · Linagliptin 5mg
Tablet · Prescription medication · Combination
Daewon Pharmaceutical Co., Ltd.
Empagliflozin 10mg · Linagliptin 5mg
Tablet · Prescription medication · Combination
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.